{
  "meta": {
    "title": "Organ_Function_Test",
    "url": "https://brainandscalpel.vercel.app/organ-function-test-7c01f500.html",
    "scrapedAt": "2025-11-30T07:37:12.282Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">TSH</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Free T4</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Anti-Thyroid Peroxidase (anti-TPO) antibodies</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum Calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which test is typically used to confirm the diagnosis of thyroid autoimmunity?</span></p>",
      "unique_key": "DT1295621",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295621,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Anti-TPO antibodies</strong> detect autoantibodies against thyroid peroxidase, an enzyme essential for thyroid hormone synthesis.</li>\r\n<li><strong>Highly sensitive and specific</strong> for autoimmune thyroid diseases such as:\r\n<ul>\r\n<li><strong>Hashimoto's thyroiditis:</strong> Present in 90-95% of cases.</li>\r\n<li><strong>Graves' disease:</strong> Less commonly present.</li>\r\n</ul>\r\n</li>\r\n<li>Helps predict <strong>progression to hypothyroidism</strong> in subclinical cases.</li>\r\n<li>Anti-TPO antibodies are the primary diagnostic tool for thyroid autoimmunity.</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ul>\r\n<li><strong>A) TSH:</strong>\r\n<ul>\r\n<li>Measures thyroid function and detects hypothyroidism or hyperthyroidism but does not identify autoimmune causes.</li>\r\n<li>Elevated in primary hypothyroidism; suppressed in hyperthyroidism.</li>\r\n</ul>\r\n</li>\r\n<li><strong>B) Free T4:</strong>\r\n<ul>\r\n<li>Reflects circulating thyroxine levels, which indicate thyroid hormone production but do not confirm autoimmune involvement.</li>\r\n<li>Abnormal levels are nonspecific for autoimmune thyroid diseases.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D) Serum Calcium:</strong>\r\n<ul>\r\n<li>Primarily used to assess parathyroid function or calcium imbalances.</li>\r\n<li>Irrelevant to thyroid function or autoimmune conditions.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Anti-TPO antibodies</strong> are the most reliable marker for diagnosing <strong>Hashimoto's thyroiditis</strong> and predicting hypothyroidism.</li>\r\n<li><strong>TSI antibodies</strong> are specific for <strong>Graves' disease</strong>, while <strong>Anti-TG antibodies</strong> are supportive but less specific for autoimmune thyroid conditions.</li>\r\n<li>TSH and Free T4 indicate thyroid dysfunction but not its autoimmune etiology.</li>\r\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Deiodinase</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid peroxidase</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Iodide transporter</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">5'-deiodinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which enzyme is responsible for the iodination of tyrosine residues in the thyroid follicle?</span></p>",
      "unique_key": "DT1296037",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Thyroid peroxidase (TPO)</strong> is an essential enzyme in thyroid hormone synthesis. It catalyzes two major reactions:\n<ul>\n<li>Oxidation of iodide to iodine.</li>\n<li><strong>Iodination of tyrosine residues</strong> on thyroglobulin, forming monoiodotyrosine (MIT) and diiodotyrosine (DIT).</li>\n</ul>\n</li>\n<li>TPO also facilitates the coupling of MIT and DIT to produce thyroid hormones T3 (triiodothyronine) and T4 (thyroxine).</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011083e6e85d-4c41-4433-bbc8-31ca8e165e40.jpg\">\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>A) Deiodinase:</strong>\n<ul>\n<li>Deiodinases remove iodine atoms from thyroid hormones to regulate their activity, converting T4 into active T3 or reverse T3.</li>\n<li>Not involved in the iodination step of thyroid hormone synthesis.</li>\n</ul>\n</li>\n<li><strong>C) Iodide transporter:</strong>\n<ul>\n<li>Also called the sodium-iodide symporter (NIS), it transports iodide into thyroid follicular cells.</li>\n<li>Plays a role in iodine uptake but not in iodination.</li>\n</ul>\n</li>\n<li><strong>D) 5'-deiodinase:</strong>\n<ul>\n<li>A subtype of deiodinase enzymes that specifically converts T4 to T3 in peripheral tissues.</li>\n<li>Has no role in thyroid follicular iodination.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Thyroid peroxidase (TPO)</strong> is critical for iodination and coupling of tyrosine residues, essential for thyroid hormone synthesis.</li>\n<li><strong>Deiodinase enzymes</strong> regulate thyroid hormone activity by modifying iodine content in T3 and T4.</li>\n<li><strong>Iodide transporter (NIS)</strong> concentrates iodide within the thyroid but does not mediate iodination.</li>\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Regulation of blood glucose levels</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Catalysis of bicarbonate formation</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Reabsorption of amino acids</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of urea to ammonia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the primary physiological role of the enzyme carbonic anhydrase in the kidneys?</span></p>",
      "unique_key": "DT1296038",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Carbonic anhydrase</strong> facilitates the reversible reaction:<br /> CO<sub>2</sub> + H<sub>2</sub>O &harr; H<sub>2</sub>CO<sub>3</sub> &harr; H<sup>+</sup> + HCO<sub>3</sub><sup>-</sup>\n<ul>\n<li>This reaction is critical in the <strong>proximal tubules</strong> of the kidneys for:\n<ul>\n<li><strong>Bicarbonate reabsorption</strong> to prevent metabolic acidosis.</li>\n<li>Excretion of H+ into the tubular lumen to regulate body pH.</li>\n</ul>\n</li>\n<li>It ensures optimal buffering of hydrogen ions and bicarbonate in the blood.</li>\n</ul>\n</li>\n<li>Carbonic anhydrase activity also aids in <strong>urine acidification</strong>, necessary for removing acids produced by metabolism.</li>\n<li><strong>Inhibitors of carbonic anhydrase</strong> (e.g., acetazolamide):\n<ul>\n<li>Promote bicarbonate excretion, leading to mild metabolic acidosis.</li>\n<li>Used therapeutically for conditions like metabolic alkalosis, altitude sickness, and glaucoma.</li>\n</ul>\n</li>\n<li>It supports the body's <strong>homeostatic mechanisms</strong> by maintaining the balance between CO2 transport, blood buffering, and renal pH adjustments.</li>\n</ul>\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>A) Regulation of blood glucose levels:</strong>\n<ul>\n<li>This is controlled by insulin, glucagon, and renal glucose transporters, not carbonic anhydrase.</li>\n</ul>\n</li>\n<li><strong>C) Reabsorption of amino acids:</strong>\n<ul>\n<li>Mediated by specialized amino acid transporters in the proximal tubule, not involving carbonic anhydrase.</li>\n</ul>\n</li>\n<li><strong>D) Conversion of urea to ammonia:</strong>\n<ul>\n<li>Performed by urease (in bacteria) and occurs in the gastrointestinal system, not in human kidneys.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Carbonic anhydrase</strong> is crucial for:\n<ul>\n<li>Bicarbonate reabsorption, acid-base balance, and urine acidification.</li>\n</ul>\n</li>\n<li>Therapeutic applications include treating glaucoma, altitude sickness, metabolic alkalosis, and epilepsy.</li>\n<li>Carbonic anhydrase inhibitors also help stabilize neurons and are being explored in cancer therapy.</li>\n</ul>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum urea</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine osmolality</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine pH</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum potassium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which test is used to assess tubular reabsorption capacity and is particularly useful in detecting early renal dysfunction?</span></p>",
      "unique_key": "DT1296039",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Urine osmolality</strong> measures the concentration of solutes in the urine, reflecting the kidney's ability to concentrate or dilute urine.</li>\n<li>It directly assesses <strong>tubular reabsorption and concentrating capacity</strong>, making it ideal for detecting early tubular dysfunction, especially in conditions like diabetes insipidus, acute tubular necrosis, or early-stage chronic kidney disease (CKD).</li>\n<li>Abnormal urine osmolality values often indicate defects in the <strong>renal medullary gradient</strong> or tubular transport mechanisms.</li>\n<li>This test is also used to differentiate between <strong>prerenal and renal causes of acute kidney injury</strong> (AKI).</li>\n</ul>\n<p><strong>Clinical Correlation:</strong></p>\n<ul>\n<li><strong>Low urine osmolality:</strong> Seen in <strong>diabetes insipidus</strong>, AKI due to tubular damage, or water intoxication.</li>\n<li><strong>High urine osmolality:</strong> Occurs in <strong>dehydration, syndrome of inappropriate ADH secretion (SIADH)</strong>, or prerenal AKI.</li>\n</ul>\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>A) Serum urea:</strong>\n<ul>\n<li>Reflects nitrogenous waste accumulation but is influenced by factors like dehydration, protein intake, and liver function.</li>\n<li>It is an indirect marker of kidney function and does not evaluate tubular reabsorption.</li>\n</ul>\n</li>\n<li><strong>C) Urine pH:</strong>\n<ul>\n<li>Indicates acid-base status, which is regulated by the kidneys but does not assess tubular reabsorption directly.</li>\n<li>Urine pH is primarily useful in diagnosing conditions like <strong>renal tubular acidosis (RTA)</strong> or metabolic disorders.</li>\n</ul>\n</li>\n<li><strong>D) Serum potassium:</strong>\n<ul>\n<li>Indicates electrolyte balance but changes occur only in advanced kidney dysfunction.</li>\n<li>It reflects tubular function indirectly but lacks sensitivity in detecting early tubular damage.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Additional Points:</strong></p>\n<ul>\n<li><strong>Urine osmolality vs. Specific Gravity:</strong>\n<ul>\n<li>Urine specific gravity is simpler but less accurate, as it can be influenced by substances like glucose or proteins.</li>\n<li>Urine osmolality directly reflects solute concentration and is more precise for assessing tubular function.</li>\n</ul>\n</li>\n<li><strong>Diagnostic Uses:</strong>\n<ul>\n<li>Helps differentiate between <strong>central diabetes insipidus (low ADH secretion)</strong> and <strong>nephrogenic diabetes insipidus (ADH resistance)</strong>.</li>\n<li>Monitors response to therapy in patients with conditions affecting water balance, such as SIADH or hypernatremia.</li>\n</ul>\n</li>\n<li><strong>Other Complementary Tests:</strong>\n<ul>\n<li><strong>Fractional excretion of sodium (FENa):</strong> Differentiates prerenal and renal causes of AKI by assessing tubular sodium handling.</li>\n<li><strong>Water deprivation test:</strong> Used alongside urine osmolality to diagnose diabetes insipidus.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Urine osmolality</strong> is critical for assessing tubular reabsorption and concentrating capacity, making it highly sensitive for early renal dysfunction.</li>\n<li>It helps in identifying conditions like diabetes insipidus, SIADH, and tubular defects, often before changes in GFR or serum markers are observed.</li>\n<li>Complementary tests like FENa and water deprivation enhance diagnostic accuracy for tubular and water balance disorders.</li>\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 1 RTA (Distal RTA)</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2 RTA (Proximal RTA)</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 3 RTA</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 4 RTA (Hyperkalemic RTA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In renal tubular acidosis (RTA), which type of RTA is associated with a defect in the renal tubule's ability to secrete hydrogen ions?</span></p>",
      "unique_key": "DT1296040",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Type 1 RTA (Distal RTA):</strong>\n<ul>\n<li>Defect in the <strong>distal tubule's ability to secrete hydrogen ions (H<sup>+</sup>)</strong>.</li>\n<li>Results in an <strong>inability to acidify urine below pH 5.5</strong>, leading to metabolic acidosis.</li>\n<li>Common features: <strong>hypokalemia</strong>, <strong>kidney stones</strong>, and <strong>bone demineralization</strong>.</li>\n<li>Associated conditions: <strong>autoimmune diseases (e.g., Sj&ouml;gren's syndrome)</strong>, <strong>genetic mutations</strong>, or nephrotoxic drugs.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>B) Type 2 RTA (Proximal RTA):</strong>\n<ul>\n<li>Defect in <strong>bicarbonate reabsorption</strong> in the proximal tubule.</li>\n<li>Distal tubule remains functional, allowing urine acidification.</li>\n<li>Typically associated with <strong>Fanconi syndrome</strong>, <strong>osteomalacia</strong>, and <strong>milder acidosis</strong> than Type 1 RTA.</li>\n</ul>\n</li>\n<li><strong>C) Type 3 RTA:</strong>\n<ul>\n<li>Rare and often considered a <strong>combination of Type 1 and Type 2 RTA</strong>.</li>\n<li>Involves mixed defects in both <strong>proximal bicarbonate reabsorption</strong> and <strong>distal H+ secretion</strong>.</li>\n<li>Not commonly referenced clinically due to its rarity.</li>\n</ul>\n</li>\n<li><strong>D) Type 4 RTA (Hyperkalemic RTA):</strong>\n<ul>\n<li>Caused by <strong>aldosterone deficiency or resistance</strong>, leading to impaired <strong>sodium reabsorption</strong> and reduced <strong>H<sup>+</sup> and potassium secretion</strong>.</li>\n<li>Characterized by <strong>hyperkalemia</strong> and mild acidosis.</li>\n<li>Common in conditions like <strong>diabetes</strong>, <strong>adrenal insufficiency</strong>, or <strong>chronic kidney disease (CKD)</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Type 1 (Distal RTA):</strong> Defect in distal H<sup>+</sup> secretion; leads to <strong>acidic blood, alkaline urine, hypokalemia, and kidney stones</strong>.</li>\n<li><strong>Type 2 (Proximal RTA):</strong> Defect in HCO<sub>3</sub><sup>-</sup> reabsorption; distal tubule can still acidify urine.</li>\n<li><strong>Type 4 (Hyperkalemic RTA):</strong> Aldosterone-related defect; causes <strong>hyperkalemia and acidosis</strong>.</li>\n<li><strong>Type 3:</strong> Rare and overlaps with Type 1 and Type 2.</li>\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum Albumin</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate Aminotransferase (AST)</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilirubin</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma-Glutamyl Transferase (GGT)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which test is typically used to assess the synthetic function of the liver?</span></p>",
      "unique_key": "DT1296041",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Serum Albumin</strong> directly reflects the liver's ability to synthesize proteins, making it the key test for assessing synthetic function.</li>\n<li>A reduction in serum albumin indicates chronic liver dysfunction, such as cirrhosis, due to impaired protein synthesis.</li>\n<li>Other causes of low albumin (e.g., malnutrition, nephrotic syndrome) are not specific to liver function.</li>\n</ul>\n<p><strong>Why Not Others</strong></p>\n<ul>\n<li><strong>Option B: Aspartate Aminotransferase (AST)</strong>\n<ul>\n<li>Assesses liver cell injury, not synthetic function.</li>\n<li>Elevated AST levels indicate hepatocellular damage but do not measure the liver's ability to produce proteins.</li>\n</ul>\n</li>\n<li><strong>Option C: Bilirubin</strong>\n<ul>\n<li>Measures the liver's ability to metabolize and excrete bilirubin, reflecting <strong>excretory/metabolic function</strong>, not protein synthesis.</li>\n<li>Elevated bilirubin can occur due to hemolysis or bile duct obstruction, unrelated to liver synthetic capacity.</li>\n</ul>\n</li>\n<li><strong>Option D: Gamma-Glutamyl Transferase (GGT)</strong>\n<ul>\n<li>Reflects <strong>biliary function</strong>, especially in bile duct obstruction or alcohol-related liver disease.</li>\n<li>It does not assess the liver's protein-synthesizing ability.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways</strong></p>\n<ul>\n<li><strong>Serum Albumin</strong> and <strong>PT/INR</strong> are the primary tests to assess <strong>synthetic liver function</strong>.</li>\n<li>AST/ALT indicate <strong>hepatocellular damage</strong>, while bilirubin reflects <strong>excretory function</strong>.</li>\n<li>GGT and ALP help assess <strong>biliary function</strong> but do not measure synthetic capacity.</li>\n</ul>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Unconjugated bilirubin</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated bilirubin</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum albumin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Urinary urobilinogen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a patient with obstructive jaundice, which of the following would likely be elevated?</span></p>",
      "unique_key": "DT1296042",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296042,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Conjugated bilirubin</strong> (direct bilirubin) is elevated in obstructive jaundice because bile flow is blocked, causing conjugated bilirubin to back up into the bloodstream.</li>\r\n<li><strong>Unconjugated bilirubin</strong> is elevated in hemolytic jaundice, not in obstructive jaundice.</li>\r\n<li><strong>Serum albumin</strong> is not typically affected in acute obstructive jaundice but may decrease in chronic liver diseases.</li>\r\n<li><strong>Urinary urobilinogen</strong> is absent or low in obstructive jaundice because conjugated bilirubin cannot reach the intestines to form urobilinogen.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) Unconjugated bilirubin:</strong> Elevated in hemolytic jaundice, not in obstructive jaundice.</li>\r\n<li><strong>C) Serum albumin:</strong> Not typically affected in obstructive jaundice; more relevant in chronic liver conditions.</li>\r\n<li><strong>D) Urinary urobilinogen:</strong> Decreased or absent in obstructive jaundice due to the lack of bilirubin in the intestines.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Indirect bilirubin</strong> increases in hemolytic jaundice.</li>\r\n<li><strong>Direct bilirubin</strong> increases in obstructive jaundice.</li>\r\n<li><strong>Hepatocellular jaundice</strong> shows an increase in both direct and indirect bilirubin.</li>\r\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral hepatitis</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune hepatitis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemochromatosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of non-alcoholic fatty liver disease (NAFLD)?</span></p>",
      "unique_key": "DT1296044",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Obesity</strong> is the leading cause of NAFLD, with visceral fat playing a critical role in developing insulin resistance and fat accumulation in the liver. It is strongly associated with metabolic syndrome and type 2 diabetes.</li>\r\n<li><strong>Viral hepatitis</strong> (e.g., hepatitis B or C) leads to liver inflammation and damage but is not a primary cause of NAFLD, which is metabolic in origin.</li>\r\n<li><strong>Autoimmune hepatitis</strong> is a condition where the immune system attacks the liver, leading to inflammation, but it does not contribute to the fat buildup seen in NAFLD.</li>\r\n<li><strong>Hemochromatosis</strong> is a genetic disorder causing excessive iron accumulation in the liver, but it is not associated with fat deposition in NAFLD.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) Viral hepatitis:</strong> While viral hepatitis can lead to liver damage, it does not directly cause fat accumulation in the liver seen in NAFLD.</li>\r\n<li><strong>C) Autoimmune hepatitis:</strong> It leads to liver inflammation but does not cause the fat buildup characteristic of NAFLD.</li>\r\n<li><strong>D) Hemochromatosis:</strong> Causes iron overload in the liver, but this does not result in fatty liver, which is central to NAFLD.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Obesity</strong> is the primary cause of NAFLD, often associated with metabolic syndrome.</li>\r\n<li><strong>Metabolic syndrome</strong> involves abdominal obesity, insulin resistance (elevated blood glucose), hypertension, elevated triglycerides, and low HDL cholesterol.</li>\r\n<li>NAFLD can progress to non-alcoholic steatohepatitis (NASH), which may lead to liver fibrosis and cirrhosis.</li>\r\n<li>Lifestyle modifications, particularly <strong>weight loss</strong>, are essential in managing and preventing the progression of NAFLD.</li>\r\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Portal hypertension</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic fibrosis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of hepatocellular carcinoma</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic cysts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In non-alcoholic steatohepatitis (NASH), which of the following is a key histological finding?</span></p>",
      "unique_key": "DT1296045",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Hepatic fibrosis</strong> is a critical histological feature of NASH. It represents scar tissue accumulation in the liver due to persistent inflammation and hepatocyte injury, which can progress to cirrhosis.</li>\r\n<li><strong>Portal hypertension</strong> is a clinical sign, not a histological feature, and typically arises from advanced liver diseases like cirrhosis rather than from NASH itself.</li>\r\n<li><strong>Hepatocellular carcinoma (HCC)</strong> can develop as a complication of cirrhosis, which may result from advanced NASH, but it is not a primary histological feature of NASH.</li>\r\n<li><strong>Hepatic cysts</strong> are unrelated to NASH and are generally benign, not a feature of NASH histology.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) Portal hypertension:</strong> It is a clinical manifestation of liver disease, not a histological finding in NASH.</li>\r\n<li><strong>C) Presence of hepatocellular carcinoma:</strong> HCC is a potential complication of advanced liver disease like cirrhosis, not a direct histological sign of NASH.</li>\r\n<li><strong>D) Hepatic cysts:</strong> These are benign and unrelated to NASH, with no impact on liver histology in this context.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Hepatic fibrosis</strong> is the key histological feature of NASH, indicating ongoing liver damage and scarring.</li>\r\n<li>NASH involves <strong>hepatocyte steatosis</strong>, <strong>lobular inflammation</strong>, <strong>hepatocyte ballooning</strong>, and <strong>Mallory-Denk bodies</strong> in addition to fibrosis.</li>\r\n<li>The progression of NASH can lead to cirrhosis and increase the risk of <strong>hepatocellular carcinoma</strong>.</li>\r\n</ul>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">ACTH stimulation test</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone suppression test</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">24-hour urine cortisol test</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Cosyntropin stimulation test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following tests is used to assess the functioning of the adrenal glands in a patient suspected of having Cushing's syndrome?</span></p>",
      "unique_key": "DT1296046",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296046,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Dexamethasone suppression test</strong> is a key diagnostic tool for <strong>Cushing's syndrome</strong>. It uses dexamethasone, a synthetic glucocorticoid, to suppress cortisol production. In healthy individuals, this suppresses cortisol levels, but in Cushing's syndrome, cortisol remains elevated due to abnormal cortisol production, either from the adrenal glands, pituitary, or ectopic sources.</li>\r\n<li><strong>ACTH stimulation test</strong> is used to assess adrenal insufficiency (Addison's disease), not Cushing's syndrome.</li>\r\n<li><strong>24-hour urine cortisol test</strong> measures total cortisol excretion over 24 hours. While useful for diagnosing Cushing's syndrome, it is typically a screening test, not a confirmatory one.</li>\r\n<li><strong>Cosyntropin stimulation test</strong> is similar to the ACTH stimulation test and assesses adrenal function, particularly in suspected adrenal insufficiency, but it is not used for diagnosing Cushing's syndrome.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) ACTH stimulation test:</strong> Used for adrenal insufficiency (Addison's disease), not for Cushing's syndrome.</li>\r\n<li><strong>C) 24-hour urine cortisol test:</strong> A screening tool but not the most specific or confirmatory for Cushing's syndrome.</li>\r\n<li><strong>D) Cosyntropin stimulation test:</strong> Used for assessing adrenal insufficiency, not Cushing's syndrome.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>dexamethasone suppression test</strong> is one of the most useful tests for diagnosing <strong>Cushing's syndrome</strong>, as it evaluates cortisol response to dexamethasone.</li>\r\n<li>The <strong>24-hour urine cortisol test</strong> is often used as an initial screening tool to detect excess cortisol production.</li>\r\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypokalemia</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Ambiguous genitalia in females</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperglycemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a common clinical feature of classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency?</span></p>",
      "unique_key": "DT1296047",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Ambiguous genitalia in females</strong> is a key clinical feature of <strong>classic congenital adrenal hyperplasia (CAH)</strong> due to <strong>21-hydroxylase deficiency</strong>. This deficiency causes decreased cortisol and aldosterone production, leading to increased ACTH and excessive androgen production, which can result in virilization of females, manifesting as ambiguous genitalia (e.g., clitoromegaly or labial fusion) at birth.</li>\r\n<li><strong>Hypertension</strong> is not a typical feature in <strong>21-hydroxylase deficiency</strong> because of decreased aldosterone, leading to salt wasting, hypotension, not hypertension.</li>\r\n<li><strong>Hypokalemia</strong> is also not common in <strong>21-hydroxylase deficiency</strong>; instead, <strong>hyperkalemia</strong> is observed due to aldosterone deficiency, causing salt wasting and electrolyte imbalances.</li>\r\n<li><strong>Hyperglycemia</strong> is not characteristic of <strong>21-hydroxylase deficiency</strong>. In fact, <strong>hypoglycemia</strong> may be more common, as reduced cortisol levels impair glucose regulation, especially during stress.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) Hypertension:</strong> Not typical in 21-hydroxylase deficiency. Hypotension occurs due to aldosterone deficiency and salt wasting.</li>\r\n<li><strong>B) Hypokalemia:</strong> Not observed in 21-hydroxylase deficiency; hyperkalemia is common due to aldosterone deficiency.</li>\r\n<li><strong>D) Hyperglycemia:</strong> Not associated with 21-hydroxylase deficiency. Reduced cortisol levels may lead to hypoglycemia instead.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>21-hydroxylase deficiency</strong> in <strong>classic CAH</strong> leads to <strong>ambiguous genitalia in females</strong> due to excess androgen production.</li>\r\n<li><strong>Salt wasting</strong> and <strong>hypotension</strong> are common in <strong>21-hydroxylase deficiency</strong>.</li>\r\n<li><strong>CAH</strong> is <strong>autosomal recessive</strong> and is caused by enzyme deficiencies in adrenal steroid synthesis.</li>\r\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum cortisol</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum aldosterone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">17-Hydroxyprogesterone (17-OHP)</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ACTH</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In 21-hydroxylase deficiency, which of the following laboratory findings is typically elevated?</span></p>",
      "unique_key": "DT1296048",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>17-Hydroxyprogesterone (17-OHP)</strong> is a precursor in the cortisol synthesis pathway. In <strong>21-hydroxylase deficiency</strong>, the enzyme block prevents 17-OHP from being converted further, leading to its <strong>accumulation</strong>. Elevated 17-OHP levels are a hallmark laboratory finding and are critical for diagnosing the condition.</li>\r\n<li><strong>Serum cortisol</strong> is typically low due to the enzymatic block in cortisol synthesis, which disrupts the pathway.</li>\r\n<li><strong>Serum aldosterone</strong> is usually low or normal, especially in the <strong>salt-wasting form</strong>, as aldosterone synthesis is impaired.</li>\r\n<li><strong>Serum ACTH</strong> is elevated as a compensatory response to low cortisol levels but is not the primary diagnostic marker.</li>\r\n</ul>\r\n<p><strong>Why Not Others:</strong></p>\r\n<ul>\r\n<li><strong>A) Serum cortisol:</strong> Cortisol is decreased because 21-hydroxylase is essential for cortisol production.</li>\r\n<li><strong>B) Serum aldosterone:</strong> Often low or normal due to impaired aldosterone synthesis in this condition, leading to salt-wasting symptoms.</li>\r\n<li><strong>D) Serum ACTH:</strong> Elevated due to lack of negative feedback from cortisol, but it is not a specific diagnostic marker.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Elevated 17-OHP</strong> is a diagnostic hallmark of <strong>21-hydroxylase deficiency</strong>.</li>\r\n<li><strong>Low cortisol</strong> and <strong>aldosterone</strong> with <strong>high ACTH</strong> are characteristic findings in this enzyme deficiency.</li>\r\n<li>CAH commonly presents with virilization in females, salt-wasting in severe cases, and increased androgen levels.</li>\r\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac-specific Troponin I</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenomedullin</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Copeptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which biomarker is used to evaluate myocardial injury in the context of chronic heart failure?</span></p>",
      "unique_key": "DT1296049",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Cardiac-specific Troponin I</strong>:\n<ul>\n<li>Troponin I is a structural protein released from damaged cardiomyocytes.</li>\n<li>It provides <strong>high specificity</strong> and <strong>sensitivity</strong> for detecting myocardial injury, including ongoing injury in chronic heart failure.</li>\n<li>Chronic elevation in heart failure suggests <strong>progressive myocardial stress or cell death</strong>, often associated with poor prognosis.</li>\n<li>Unlike NT-proBNP, troponins directly reflect <strong>cardiomyocyte damage</strong> rather than hemodynamic stress.</li>\n</ul>\n</li>\n<li><strong>NT-proBNP</strong>:\n<ul>\n<li>Released in response to <strong>increased ventricular wall stress</strong> and <strong>volume overload</strong>.</li>\n<li>It is widely used for <strong>diagnosing and monitoring heart failure</strong>, but it is influenced by non-specific factors like <strong>renal dysfunction</strong> or age.</li>\n<li>Elevated levels in heart failure <strong>do not directly indicate myocardial cell injury</strong>.</li>\n</ul>\n</li>\n<li><strong>Adrenomedullin</strong>:\n<ul>\n<li>Plays a role in <strong>vascular tone regulation</strong> and <strong>fluid homeostasis</strong>.</li>\n<li>Elevated in heart failure but lacks specificity for heart muscle injury.</li>\n<li>Research indicates its potential as a prognostic marker for heart failure severity rather than direct myocardial damage.</li>\n</ul>\n</li>\n<li><strong>Copeptin</strong>:\n<ul>\n<li>A surrogate marker for <strong>arginine vasopressin (AVP)</strong>, reflecting neurohormonal activation in heart failure.</li>\n<li>Associated with <strong>cardiovascular stress</strong> and poor outcomes but does not indicate specific myocardial damage.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others :</strong></p>\n<ul>\n<li><strong>A) NT-proBNP</strong>:\n<ul>\n<li>A well-established biomarker for <strong>wall stress and heart failure severity</strong>, but its levels are not specific to myocardial injury and are influenced by other factors like kidney function.</li>\n</ul>\n</li>\n<li><strong>C) Adrenomedullin</strong>:\n<ul>\n<li>A general marker for <strong>vascular and cardiac stress</strong>, elevated in various conditions including sepsis and heart failure, but lacks diagnostic value for myocardial injury.</li>\n</ul>\n</li>\n<li><strong>D) Copeptin</strong>:\n<ul>\n<li>A <strong>general stress marker</strong>, elevated in several systemic conditions, including heart failure and other states of acute stress, making it non-specific for myocardial damage.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways :</strong></p>\n<ul>\n<li><strong>Troponin I</strong> is the most specific biomarker for assessing <strong>myocardial injury</strong> in chronic heart failure, indicating ongoing cardiomyocyte damage.</li>\n<li><strong>NT-proBNP</strong> provides insights into <strong>heart failure severity</strong> and <strong>ventricular wall stress</strong>, not myocardial damage.</li>\n<li>Biomarkers like <strong>adrenomedullin</strong> and <strong>copeptin</strong> have emerging roles in prognosis but lack specificity for detecting cardiomyocyte injury.</li>\n</ul>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">High-sensitivity C-reactive Protein (hs-CRP)</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">CK-mb</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Brain Natriuretic Peptide (BNP)</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactate Dehydrogenase (LDH)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which biomarker is associated with inflammation and is used to predict cardiovascular events and risk?</span></p>",
      "unique_key": "DT1296050",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>High-sensitivity C-reactive Protein (hs-CRP):</strong>\n<ul>\n<li>hs-CRP is an <strong>inflammatory biomarker</strong> that reflects <strong>low-grade systemic inflammation</strong>, which is central to atherosclerosis and plaque formation.</li>\n<li>Elevated levels predict the risk of <strong>cardiovascular events</strong> such as myocardial infarction, stroke, and sudden cardiac death.</li>\n<li>It is particularly valuable for risk stratification in <strong>asymptomatic individuals</strong> and those with intermediate cardiovascular risk.</li>\n</ul>\n</li>\n<li><strong>CK-MB:</strong>\n<ul>\n<li>A cardiac enzyme used to detect <strong>acute myocardial injury</strong>.</li>\n<li>CK-MB levels rise following <strong>myocardial infarction</strong>, but they do not indicate systemic inflammation or predict future cardiovascular events.</li>\n</ul>\n</li>\n<li><strong>Brain Natriuretic Peptide (BNP):</strong>\n<ul>\n<li>A marker of <strong>heart failure</strong>; elevated levels indicate <strong>ventricular wall stress</strong>.</li>\n<li>BNP is not associated with inflammation or cardiovascular risk prediction outside the context of heart failure.</li>\n</ul>\n</li>\n<li><strong>Lactate Dehydrogenase (LDH):</strong>\n<ul>\n<li>A non-specific enzyme elevated in <strong>tissue damage</strong>, such as hemolysis, liver disease, or muscle injury.</li>\n<li>LDH lacks specificity for cardiovascular diseases or inflammation.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others:</strong></p>\n<ul>\n<li><strong>B) CK-MB:</strong>\n<ul>\n<li>Indicates <strong>acute myocardial cell injury</strong> but not <strong>systemic inflammation</strong> or long-term cardiovascular risk.</li>\n</ul>\n</li>\n<li><strong>C) BNP:</strong>\n<ul>\n<li>A marker for <strong>ventricular stress</strong> in heart failure, but it is unrelated to systemic inflammation or cardiovascular event prediction.</li>\n</ul>\n</li>\n<li><strong>D) LDH:</strong>\n<ul>\n<li>A general marker for <strong>tissue damage</strong> with no specific role in cardiovascular inflammation or risk prediction.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>hs-CRP</strong> is a critical biomarker for <strong>systemic inflammation</strong> and is widely used to assess the risk of future cardiovascular events.</li>\n<li>CK-MB, BNP, and LDH lack the specificity and relevance for predicting inflammation-mediated cardiovascular risk.</li>\n</ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Creatine kinase (CK)</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Myoglobin</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Troponin I</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-type natriuretic peptide (BNP)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which cardiac biomarker is considered the most sensitive and specific for myocardial infarction?</span></p>",
      "unique_key": "DT1296051",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Troponin I</strong> is the <strong>most sensitive and specific</strong> biomarker for myocardial infarction.</li>\r\n<li>It is <strong>highly specific</strong> to cardiac muscle, released upon myocardial cell damage.</li>\r\n<li>Levels rise <strong>3-6 hours after MI</strong>, peak at 12-24 hours, and remain elevated for 7-10 days, offering a broad diagnostic window.</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ol style=\"list-style-type: upper-alpha;\">\r\n<li><strong> Creatine kinase (CK):</strong>\r\n<ul>\r\n<li>CK-MB isoform is cardiac-specific but <strong>less sensitive and specific</strong> than troponin.</li>\r\n<li>CK can elevate in skeletal muscle injuries, limiting its specificity.</li>\r\n</ul>\r\n</li>\r\n<li><strong> Myoglobin:</strong>\r\n<ul>\r\n<li>Early marker but <strong>non-specific</strong> to the heart as it is found in all muscle tissue.</li>\r\n<li>Elevates with any muscle injury, reducing diagnostic reliability for MI.</li>\r\n</ul>\r\n</li>\r\n<li><strong> Beta-type natriuretic peptide (BNP):</strong>\r\n<ul>\r\n<li><strong>Specific to heart failure</strong>, not myocardial infarction.</li>\r\n<li>Reflects ventricular stress and overload, not myocardial cell death.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Troponin I</strong>: Most sensitive and specific biomarker for MI, rises early and stays elevated for days.</li>\r\n<li><strong>CK and Myoglobin</strong>: Less specific, may elevate due to other muscle injuries.</li>\r\n<li><strong>BNP</strong>: Marker of heart failure, unrelated to MI diagnosis.</li>\r\n</ul>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Creatine kinase</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta-type natriuretic peptide (BNP)</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac troponin</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">C-reactive protein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the context of heart failure, which biomarker is primarily used to assess the severity of the condition?</span></p>",
      "unique_key": "DT1296052",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>BNP</strong> is a <strong>key biomarker for heart failure</strong> and is secreted by ventricular myocytes in response to <strong>increased ventricular wall stress</strong> caused by volume and pressure overload.</li>\r\n<li>Elevated BNP levels help differentiate <strong>heart failure</strong> from other causes of dyspnea.</li>\r\n<li>It correlates with the <strong>severity</strong> of heart failure, aiding in prognosis and <strong>monitoring response to therapy</strong>.</li>\r\n<li>Normal or low BNP levels make heart failure unlikely, enhancing its diagnostic accuracy.</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<p><strong>A. Creatine kinase (CK):</strong></p>\r\n<ul>\r\n<li>Primarily indicates <strong>muscle injury</strong> and is non-specific for cardiac conditions.</li>\r\n<li>CK-MB, a cardiac isoenzyme, is useful in diagnosing <strong>acute myocardial infarction</strong>, but neither are used for heart failure severity assessment.</li>\r\n</ul>\r\n<p><strong>C. Cardiac troponin:</strong></p>\r\n<ul>\r\n<li>Highly specific for <strong>myocardial injury</strong> and used in diagnosing myocardial infarction.</li>\r\n<li>Can be elevated in <strong>severe heart failure</strong> due to secondary myocardial stress or ischemia but <strong>lacks specificity</strong> for chronic heart failure.</li>\r\n</ul>\r\n<p><strong>D. C-reactive protein (CRP):</strong></p>\r\n<ul>\r\n<li>Indicates <strong>systemic inflammation</strong> and may rise in cardiovascular conditions like heart failure, but it is <strong>non-specific</strong> and cannot quantify heart failure severity.</li>\r\n<li>Its role is more relevant in identifying inflammatory components of atherogenesis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>BNP</strong>: The gold standard for diagnosing and assessing the severity of heart failure, reflecting ventricular stress and overload.</li>\r\n<li><strong>CK</strong>: Indicates general muscle injury, not specific to heart failure.</li>\r\n<li><strong>Troponin</strong>: Useful for myocardial infarction, not for heart failure severity.</li>\r\n<li><strong>CRP</strong>: A non-specific inflammation marker, irrelevant for diagnosing or staging heart failure.</li>\r\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">4-6 hours</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">12-24 hours</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">24-48 hours</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the typical time frame for troponin levels to rise after myocardial injury?</span></p>",
      "unique_key": "DT1296053",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Troponins (I and T)</strong> are structural proteins of the cardiac muscle, released into the bloodstream upon myocardial cell injury or necrosis.</li>\r\n<li>Levels start to <strong>rise 4-6 hours</strong> post-injury, making them effective for early diagnosis of myocardial infarction (MI).</li>\r\n<li><strong>Troponin I</strong> peaks within <strong>12-24 hours</strong> and remains elevated for <strong>5-10 days</strong>, while <strong>Troponin T</strong> peaks within <strong>12-48 hours</strong> and stays elevated for <strong>10-14 days</strong>, providing a long diagnostic window.</li>\r\n<li>They are considered the <strong>gold standard</strong> biomarkers for MI due to their <strong>high specificity and sensitivity</strong> for cardiac muscle injury.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110c3823c92-25f8-4a18-a9ca-2d10dc0d4d31.jpg\">\r\n<p><strong>Why Not Others?</strong></p>\r\n<p><strong>B. 12-24 hours:</strong></p>\r\n<ul>\r\n<li>Represents the <strong>peak time</strong> for troponin levels, not the time when levels start rising.</li>\r\n</ul>\r\n<p><strong>C. 24-48 hours:</strong></p>\r\n<ul>\r\n<li>Applies to the <strong>peak phase</strong> of Troponin T but not its initial rise.</li>\r\n</ul>\r\n<p><strong>D. 1-2 hours:</strong></p>\r\n<ul>\r\n<li>Refers to <strong>myoglobin</strong>, the earliest cardiac biomarker to rise (1-3 hours), but it is non-specific to myocardial injury.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Troponins (I and T):</strong> Begin rising 4-6 hours post-injury, with high specificity and a long diagnostic window (5-14 days).</li>\r\n<li><strong>Myoglobin:</strong> Rises earliest (1-3 hours), highly sensitive but lacks cardiac specificity.</li>\r\n<li><strong>CK-MB:</strong> Rises 3-6 hours post-injury, peaks in 12-24 hours, and normalizes in 2-3 days; helpful in reinfarction cases.</li>\r\n<li><strong>LDH:</strong> Rises late (10-12 hours), peaks in 48-72 hours, and remains elevated for 7-14 days but lacks cardiac specificity.</li>\r\n</ul>",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased liver function</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased vitamin K intake</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired synthetic function of the liver</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased platelet production</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the context of liver function tests, what does a prolonged prothrombin time (PT) indicate?</span></p>",
      "unique_key": "DT1296054",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296054,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Prothrombin Time (PT):</strong>\n<ul>\n<li><strong>Prolonged PT</strong> reflects impaired liver synthetic function. The liver produces clotting factors (II, VII, IX, X) dependent on vitamin K, and dysfunction results in reduced production.</li>\n</ul>\n</li>\n<li><strong>Vitamin K's Role:</strong>\n<ul>\n<li>While reduced vitamin K intake can contribute to prolonged PT, the liver must also be functioning properly to utilize vitamin K effectively.</li>\n</ul>\n</li>\n<li><strong>Liver Function Tests (LFTs):</strong>\n<ul>\n<li>Other tests such as albumin, bilirubin, ALT, AST, and ALP also provide insights into various aspects of liver function like synthetic ability, excretion, and injury.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>Option A (Increased Liver Function):</strong>\n<ul>\n<li>Prolonged PT does not indicate increased liver function. It suggests reduced production of clotting factors due to impaired synthetic activity.</li>\n</ul>\n</li>\n<li><strong>Option B (Decreased Vitamin K):</strong>\n<ul>\n<li>While vitamin K deficiency can prolong PT, liver dysfunction is more commonly the underlying cause in the context of liver disease.</li>\n</ul>\n</li>\n<li><strong>Option D (Increased Platelet Production):</strong>\n<ul>\n<li>Platelets are unrelated to PT. They influence primary hemostasis, while PT reflects the synthesis of clotting factors involved in secondary hemostasis.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Prolonged PT:</strong> Indicates impaired liver synthetic function, a hallmark of liver disease.</li>\n<li><strong>Vitamin K Deficiency:</strong> May prolong PT but usually occurs alongside liver dysfunction.</li>\n<li><strong>Platelet Levels:</strong> Do not directly affect PT, focusing on primary hemostasis rather than secondary clotting mechanisms.</li>\n<li><strong>Liver Function Insight:</strong> ALT, AST (injury), Albumin, PT/INR (synthesis), Bilirubin (excretion), ALP/GGT (biliary function).</li>\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Biliary obstruction</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolysis</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperventilation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT a common cause of elevated serum bilirubin levels?</span></p>",
      "unique_key": "DT1296055",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296055,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Biliary Obstruction:</strong>\r\n<ul>\r\n<li>Prevents excretion of <strong>conjugated bilirubin</strong> into the intestines, leading to its accumulation in the blood.</li>\r\n<li>Causes <strong>conjugated hyperbilirubinemia</strong> and symptoms like <strong>jaundice</strong>, dark urine, and pale stools.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hemolysis:</strong>\r\n<ul>\r\n<li>Increased RBC breakdown generates <strong>unconjugated bilirubin</strong>, exceeding the liver's ability to conjugate it.</li>\r\n<li>Causes <strong>unconjugated hyperbilirubinemia</strong>, typically without dark urine.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hepatitis:</strong>\r\n<ul>\r\n<li>Liver inflammation impairs <strong>bilirubin conjugation and excretion</strong>, causing both <strong>conjugated and unconjugated hyperbilirubinemia</strong>.</li>\r\n<li>Often presents with <strong>elevated liver enzymes (ALT/AST)</strong> and jaundice.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Hyperventilation:</strong>\r\n<ul>\r\n<li>Primarily affects respiratory physiology by causing <strong>respiratory alkalosis</strong>.</li>\r\n<li>Does <strong>not influence bilirubin metabolism</strong> and is not linked to elevated serum bilirubin.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ul>\r\n<li><strong>Option A (Biliary Obstruction):</strong><br /> Common cause of <strong>conjugated hyperbilirubinemia</strong>, related to impaired bile flow.</li>\r\n<li><strong>Option B (Hemolysis):</strong><br /> Causes <strong>unconjugated hyperbilirubinemia</strong> due to increased RBC breakdown.</li>\r\n<li><strong>Option C (Hepatitis):</strong><br /> Elevates both <strong>conjugated and unconjugated bilirubin</strong> due to impaired liver function.</li>\r\n<li><strong>Option D (Hyperventilation):</strong><br /> Does not affect bilirubin metabolism or levels, making it unrelated to serum bilirubin elevation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Biliary obstruction:</strong> Increases <strong>conjugated bilirubin</strong>.</li>\r\n<li><strong>Hemolysis:</strong> Leads to <strong>unconjugated hyperbilirubinemia</strong>.</li>\r\n<li><strong>Hepatitis:</strong> Impacts both <strong>conjugated and unconjugated bilirubin</strong>.</li>\r\n<li><strong>Hyperventilation:</strong> Has no impact on bilirubin metabolism or serum levels.</li>\r\n</ul>",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate aminotransferase (AST)</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine aminotransferase (ALT)</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Gamma-glutamyl transferase (GGT)</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactate dehydrogenase (LDH)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which enzyme is a marker for biliary obstruction and is often elevated in conjunction with ALP?</span></p>",
      "unique_key": "DT1296056",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296056,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Gamma-glutamyl transferase (GGT):</strong>\r\n<ul>\r\n<li>Highly specific for <strong>biliary obstruction</strong> and is often elevated with <strong>alkaline phosphatase (ALP)</strong>.</li>\r\n<li>Helps differentiate biliary causes from bone-related elevations of ALP.</li>\r\n<li>Also elevated in <strong>alcohol-related liver disease</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Aspartate Aminotransferase (AST):</strong>\r\n<ul>\r\n<li>Found in the <strong>liver, heart, and other tissues</strong>.</li>\r\n<li>Elevated in <strong>hepatocellular injury</strong>, not biliary obstruction.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Alanine Aminotransferase (ALT):</strong>\r\n<ul>\r\n<li>More liver-specific than AST but elevated in <strong>liver cell injury</strong> rather than cholestatic conditions.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Lactate Dehydrogenase (LDH):</strong>\r\n<ul>\r\n<li>Non-specific enzyme elevated in <strong>many tissue injuries</strong> but not a reliable marker for biliary obstruction.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ul>\r\n<li><strong>Option A (AST):</strong> Elevated in hepatocellular injury, such as <strong>hepatitis</strong>, but not specific for biliary obstruction.</li>\r\n<li><strong>Option B (ALT):</strong> Indicates liver damage, but like AST, it is more associated with <strong>hepatocyte damage</strong> than biliary tract conditions.</li>\r\n<li><strong>Option D (LDH):</strong> Elevated in <strong>tissue damage</strong> (e.g., hemolysis, cancer) but lacks specificity for liver or biliary diseases.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>GGT:</strong> Specific marker for <strong>biliary obstruction</strong> and alcohol-related liver injury.</li>\r\n<li><strong>ALP + GGT elevation:</strong> Suggests a <strong>biliary origin</strong>.</li>\r\n<li><strong>AST &amp; ALT:</strong> Indicative of <strong>hepatocellular injury</strong>, not biliary conditions.</li>\r\n<li><strong>LDH:</strong> Non-specific and less useful in biliary or liver-specific pathologies.</li>\r\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Parafollicular cells</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular cells</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">C-cells</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Adipocytes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the thyroid gland, which cells are responsible for synthesizing thyroid hormones?</span></p>",
      "unique_key": "DT1296057",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296057,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Follicular cells:</strong>\r\n<ul>\r\n<li>The main functional cells in the thyroid gland.</li>\r\n<li>Responsible for synthesizing <strong>thyroid hormones (T3 and T4)</strong>.</li>\r\n<li>Utilize <strong>iodine</strong> from the bloodstream and incorporate it into thyroglobulin within the follicular lumen.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Parafollicular cells (C-cells):</strong>\r\n<ul>\r\n<li>Produce <strong>calcitonin</strong>, which regulates <strong>calcium homeostasis</strong>.</li>\r\n<li>Do not play a role in thyroid hormone production.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Adipocytes:</strong>\r\n<ul>\r\n<li>Fat cells, not part of the thyroid gland, and have no endocrine function related to the thyroid.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ul>\r\n<li><strong>Option A (Parafollicular cells):</strong> Produce <strong>calcitonin</strong>, not thyroid hormones.</li>\r\n<li><strong>Option C (C-cells):</strong> Another name for parafollicular cells; their role is limited to <strong>calcitonin production</strong>.</li>\r\n<li><strong>Option D (Adipocytes):</strong> Found in fat tissue, not the thyroid gland, and unrelated to hormone synthesis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Follicular cells:</strong> Synthesize <strong>T3 and T4</strong>, essential for metabolism and growth.</li>\r\n<li><strong>Parafollicular cells (C-cells):</strong> Secrete <strong>calcitonin</strong>, involved in calcium regulation.</li>\r\n<li>Thyroid hormone synthesis relies on <strong>iodine uptake</strong> by follicular cells.</li>\r\n</ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyrotropin-releasing hormone (TRH)</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Corticotropin-releasing hormone (CRH)</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone (GH)</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocorticotropic hormone (ACTH)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which hormone stimulates the release of thyroid hormones from the thyroid gland?</span></p>",
      "unique_key": "DT1296058",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296058,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Thyrotropin-releasing hormone (TRH):</strong>\r\n<ul>\r\n<li>Secreted by the <strong>hypothalamus</strong>.</li>\r\n<li>Stimulates the anterior pituitary to release <strong>thyroid-stimulating hormone (TSH)</strong>.</li>\r\n<li>TSH directly acts on the <strong>thyroid gland</strong>, leading to the synthesis and release of <strong>T3 and T4</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Corticotropin-releasing hormone (CRH):</strong>\r\n<ul>\r\n<li>Stimulates ACTH release from the pituitary, influencing cortisol production from the adrenal cortex.</li>\r\n<li>Does not affect thyroid hormone release.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Growth hormone (GH):</strong>\r\n<ul>\r\n<li>Promotes growth and metabolism but is not involved in the thyroid hormone regulation pathway.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Adrenocorticotropic hormone (ACTH):</strong>\r\n<ul>\r\n<li>Stimulates cortisol and adrenal steroid production, unrelated to thyroid hormones.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Others?</strong></p>\r\n<ul>\r\n<li><strong>Option B (CRH):</strong> Involved in cortisol regulation, not thyroid hormones.</li>\r\n<li><strong>Option C (GH):</strong> Affects growth and metabolism, with no role in the HPT axis.</li>\r\n<li><strong>Option D (ACTH):</strong> Targets the adrenal cortex, not the thyroid gland.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>TRH &rarr; TSH &rarr; T3/T4</strong> is the hormonal cascade in the <strong>hypothalamus-pituitary-thyroid (HPT) axis</strong>.</li>\r\n<li>Negative feedback ensures balanced thyroid hormone levels by regulating TRH and TSH secretion.</li>\r\n<li>T3 and T4 are essential for <strong>metabolism, growth, and development</strong>.</li>\r\n</ul>",
      "correct_choice_id": 211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">To inhibit hormone synthesis</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">To destroy overactive thyroid tissue</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">To reduce TSH levels</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">To provide a diagnostic measure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the purpose of using radioactive iodine (RAI) in the treatment of hyperthyroidism?</span></p>",
      "unique_key": "DT1296059",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296059,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Radioactive iodine (RAI):</strong>\n<ul>\n<li><strong>Selective uptake by thyroid cells</strong>: The thyroid gland is the only tissue in the body that absorbs iodine, making RAI a targeted therapy.</li>\n<li><strong>Destroys overactive thyroid tissue:</strong> Emits beta radiation that causes localized destruction of hyperfunctioning thyroid cells, reducing hormone synthesis.</li>\n<li>Effective for treating <strong>Graves' disease</strong>, <strong>toxic multinodular goiter</strong>, and <strong>autonomous toxic nodules</strong>.</li>\n</ul>\n</li>\n<li><strong>Gradual effect:</strong> Thyroid hormone levels decrease over weeks to months post-therapy, with improvement in hyperthyroid symptoms.</li>\n<li><strong>Alternative to surgery:</strong> RAI is non-invasive, safer for patients unfit for thyroidectomy, and avoids risks of anesthesia or surgical complications.</li>\n</ul>\n<p><strong>Why Not Others?</strong></p>\n<ul>\n<li><strong>Option A:</strong> RAI does not inhibit hormone synthesis directly; drugs like methimazole or propylthiouracil achieve this effect.</li>\n<li><strong>Option C:</strong> TSH levels adjust indirectly through the hypothalamus-pituitary-thyroid axis after thyroid hormone production is reduced.</li>\n<li><strong>Option D:</strong> While small doses of RAI are used diagnostically (e.g., RAI uptake test or thyroid scans), therapeutic doses are designed to destroy overactive tissue.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>RAI is a targeted, non-invasive treatment for hyperthyroidism that destroys overactive thyroid tissue, helping to reduce hormone production.</li>\n<li>It is safe, effective, and avoids surgical risks, making it the treatment of choice in many hyperthyroid cases.</li>\n<li>Gradual effect with symptom relief observed over several weeks to months.</li>\n</ul>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Subclinical hyperthyroidism</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Hashimoto's thyroiditis</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Graves' disease</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroid storm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which type of hyperthyroidism is characterized by an autoimmune process leading to increased thyroid hormone production?</span></p>",
      "unique_key": "DT1296060",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296060,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Graves' disease</strong>:\n<ul>\n<li>An <strong>autoimmune disorder</strong> where <strong>thyroid-stimulating immunoglobulins (TSIs)</strong> mimic TSH, leading to <strong>increased thyroid hormone production</strong>.</li>\n<li>It is the <strong>most common cause of hyperthyroidism</strong>, particularly in younger individuals.</li>\n<li>Symptoms include <strong>weight loss</strong>, <strong>heat intolerance</strong>, <strong>tachycardia</strong>, <strong>tremors</strong>, and <strong>goiter</strong>.</li>\n<li>Eye manifestations, such as <strong>exophthalmos</strong> and <strong>periorbital edema</strong>, occur in Graves' ophthalmopathy, unique to this condition.</li>\n<li>Laboratory findings include <strong>elevated T3 and T4</strong> with <strong>low TSH levels</strong>.</li>\n<li>Radioactive iodine uptake (RAIU) is <strong>diffusely increased</strong> in Graves&rsquo; disease.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others:</strong></p>\n<ul>\n<li><strong>A. Subclinical hyperthyroidism</strong>:\n<ul>\n<li>Characterized by <strong>low TSH</strong> but <strong>normal T3 and T4 levels</strong>.</li>\n<li>It is usually asymptomatic or mild and does not involve autoimmune mechanisms.</li>\n<li>Causes include excessive exogenous thyroid hormone, nodular thyroid disease, or early thyroid dysfunction, not Graves&rsquo; disease.</li>\n</ul>\n</li>\n<li><strong>B. Hashimoto's thyroiditis</strong>:\n<ul>\n<li>An <strong>autoimmune hypothyroidism</strong>, where chronic inflammation leads to <strong>thyroid cell destruction</strong>.</li>\n<li>While transient hyperthyroid phases (Hashitoxicosis) can occur, they are temporary and not sustained like in Graves&rsquo; disease.</li>\n<li>Over time, Hashimoto's results in reduced thyroid hormone production, not persistent hyperthyroidism.</li>\n</ul>\n</li>\n<li><strong>D. Thyroid storm</strong>:\n<ul>\n<li>A <strong>life-threatening complication</strong> of untreated or poorly managed hyperthyroidism, not a distinct type of hyperthyroidism.</li>\n<li>It is an acute state with exaggerated hyperthyroid symptoms, such as fever, severe tachycardia, and altered mental status, triggered by stress, surgery, or infection.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Graves' disease</strong> is the leading <strong>autoimmune cause</strong> of hyperthyroidism due to overstimulation of the thyroid gland by TSIs.</li>\n<li><strong>Unique features</strong>: Diffusely increased RAIU, Graves&rsquo; ophthalmopathy, and dermopathy (e.g., pretibial myxedema).</li>\n<li>Other options represent conditions with <strong>different causes</strong> (e.g., hypothyroidism, mild dysfunction, or complications of hyperthyroidism).</li>\n</ul>",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}